F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data.


Journal

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
ISSN: 1827-1936
Titre abrégé: Q J Nucl Med Mol Imaging
Pays: Italy
ID NLM: 101213861

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 11 12 2020
medline: 21 3 2023
entrez: 10 12 2020
Statut: ppublish

Résumé

F18-FET PET has an established diagnostic role in adult brain gliomas. In this study we analyzed image derived static and dynamic parameters with available conventional MRI, histological, clinical and follow-up data in assessment of pediatric brain tumor patients at different stages of the disease. Forty-four pediatric patients with median age 7 years, diagnosed with brain tumors and underwent forty-seven 18F-FET PET scans either initially (20 scans) or post-therapy (27 scans) were enrolled. Standardized analysis of summed FET PET images early from 10-20 min and late from 30-40 min post-injection were used for static (mean and maximum tumor to brain ratio [TBR] and biological tumor volume [BTV]) parameters evaluation as well as the time activity curve [TAC]. Nineteen out of 20 initially assessed patients had pathologically and/or clinico-radiologically proven neoplastic lesions and one patient had pathologically proven abscess. Receiver operator curve (ROC) marked early TBR max 2.95, early TBR mean 1.76, late TBR max 2.5 and late TBR mean 1.74 as discriminator points with diagnostic accuracy reaching 90% when TBR max was combined with dynamic parameters. Significant association was found between initial FET scans, early and late BTV and event free survival (EFS) (P value=0.042 and 0.005 respectively). In post-therapy assessment, the diagnostic accuracy of conventional MRI was 81.48% when used alone and 96.30% when combined with F18-FET PET scan findings. A cutoff point of 3.2 cm F18-FET PET seems to be an evolving pediatric neuro-imaging technique with valuable diagnostic and prognostic information at initial and post-therapy evaluation.

Sections du résumé

BACKGROUND BACKGROUND
F18-FET PET has an established diagnostic role in adult brain gliomas. In this study we analyzed image derived static and dynamic parameters with available conventional MRI, histological, clinical and follow-up data in assessment of pediatric brain tumor patients at different stages of the disease.
METHODS METHODS
Forty-four pediatric patients with median age 7 years, diagnosed with brain tumors and underwent forty-seven 18F-FET PET scans either initially (20 scans) or post-therapy (27 scans) were enrolled. Standardized analysis of summed FET PET images early from 10-20 min and late from 30-40 min post-injection were used for static (mean and maximum tumor to brain ratio [TBR] and biological tumor volume [BTV]) parameters evaluation as well as the time activity curve [TAC].
RESULTS RESULTS
Nineteen out of 20 initially assessed patients had pathologically and/or clinico-radiologically proven neoplastic lesions and one patient had pathologically proven abscess. Receiver operator curve (ROC) marked early TBR max 2.95, early TBR mean 1.76, late TBR max 2.5 and late TBR mean 1.74 as discriminator points with diagnostic accuracy reaching 90% when TBR max was combined with dynamic parameters. Significant association was found between initial FET scans, early and late BTV and event free survival (EFS) (P value=0.042 and 0.005 respectively). In post-therapy assessment, the diagnostic accuracy of conventional MRI was 81.48% when used alone and 96.30% when combined with F18-FET PET scan findings. A cutoff point of 3.2 cm
CONCLUSIONS CONCLUSIONS
F18-FET PET seems to be an evolving pediatric neuro-imaging technique with valuable diagnostic and prognostic information at initial and post-therapy evaluation.

Identifiants

pubmed: 33300749
pii: S1824-4785.20.03267-7
doi: 10.23736/S1824-4785.20.03267-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-56

Auteurs

Mai A Elahmadawy (MA)

Unit of Nuclear Medicine, National Cancer Institute, Cairo University, Cairo, Egypt - mai.elahmadawy@nci.cu.edu.eg.
Children's Cancer Hospital, Cairo, Egypt - mai.elahmadawy@nci.cu.edu.eg.

Moatasem El-Ayadi (M)

Children's Cancer Hospital, Cairo, Egypt.
Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.

Soha Ahmed (S)

Department of Clinical Oncology, Aswan University, Aswan, Egypt.
Department of Radiation Oncology, Children's Cancer Hospital, Cairo, Egypt.

Amal Refaat (A)

Children's Cancer Hospital, Cairo, Egypt.
Department of Radio-Diagnosis, National Cancer Institute, Cairo University, Cairo, Egypt.

Magdy H Eltaoudy (MH)

Cyclotron Facility, Department of Nuclear Medicine, Children's Cancer Hospital, Cairo, Egypt.

Eslam Maher (E)

Department of Clinical Research, Children's Cancer Hospital, Cairo, Egypt.

Hala Taha (H)

Children's Cancer Hospital, Cairo, Egypt.
Department of Pathology, National Cancer Institute, Cairo, Egypt.

Mohamed Elbeltagy (M)

Department of Neurosurgery, Children's Cancer Hospital, Cairo, Egypt.
Kasr El-Ainy School of Medicine, Cairo University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH